Moore Capital Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-20,000
Closed -$10M 552
2023
Q1
$10M Buy
+20,000
New +$9.57M 0.21% 93
2020
Q3
Sell
-16,303
Closed -$5.38M 407
2020
Q2
$5.38M Buy
+16,303
New +$4.72M 0.14% 132

Other funds holding IDXX

Moore Capital Management's IDXX Position: Q2 2023 in Review

Moore Capital Management sold out of Idexx Laboratories (IDXX) in Q2 2023, closing a stake of 20,000 shares — an estimated $10M sold.

Moore Capital Management first reported a position in IDXX in Q2 2020 and held it in 2 quarters. The position peaked at $10M in Q1 2023. 1,068 funds tracked by Wall St. Rank hold IDXX as of Q2 2023.

  • Moore Capital Management reported no remaining Idexx Laboratories position as of Q2 2023 after selling out during the quarter.
  • Moore Capital Management sold 20,000 Idexx Laboratories shares in Q2 2023, an estimated $10M.
  • Moore Capital Management first reported a position in Idexx Laboratories in Q2 2020 and held it in 2 quarters.
  • Moore Capital Management's Idexx Laboratories position peaked at $10M in Q1 2023.
  • 1,068 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2023.

Based on Moore Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.